Treatment with IFN-γ-1b reduces BAL CXCL8 levels in IPF patients, indicating a potential role for IFN-γ as a modulator of angiogenic pathways during IPF [242]. Here, CXCL8 is linked to idiopathic interstitial pneumonia.